Clover Health Investments, Corp.
CLOVNasdaqCIK 1801170FinancialsFiscal year ends Dec 31
Reports and events: 149 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0923:13 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001801170-26-000250 |
| 2026-09-2521:41 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001801170-26-000232 |
| 2026-09-2420:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001801170-26-000229 |
| 2026-08-2020:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001801170-26-000214 |
| 2026-08-0712:04 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001801170-26-000200 |
| 2026-08-0520:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001801170-26-000196 |
| 2026-07-1720:05 ET | 8-K | 8.01 Other events | 0001801170-26-000181 |
| 2026-06-1820:05 ET | 8-K | 8.01 Other events | 0001801170-26-000166 |
| 2026-06-1620:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001801170-26-000153 |
| 2026-06-1220:05 ET | 8-K | 5.07 Shareholder vote results | 0001801170-26-000148 |
| 2026-06-1012:31 ET | 8-K | 8.01 Other events | 0001801170-26-000137 |
| 2026-05-1812:32 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001801170-26-000128 |
| 2026-05-0812:06 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001801170-26-000122 |
| 2026-05-0620:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001801170-26-000114 |
| 2026-04-2820:06 ET | DEF 14A | Proxy statementPeriod 2026-04-28 | 0001801170-26-000102 |
| 2026-04-0112:32 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001801170-26-000080 |
| 2026-03-0614:06 ET | 8-K/A | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001801170-26-000071 |
| 2026-03-0613:46 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001801170-26-000069 |
| 2026-02-2713:08 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001801170-26-000057 |
| 2026-02-2621:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001801170-26-000050 |
| 2026-01-1413:32 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001801170-26-000020 |
| 2025-12-1021:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001801170-25-000284 |
| 2025-11-1213:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001801170-25-000279 |
| 2025-11-0713:06 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001801170-25-000275 |
| 2025-11-0421:08 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001801170-25-000269 |
| 2025-10-3120:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001801170-25-000261 |
| 2025-10-0920:56 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001801170-25-000253 |
| 2025-08-1120:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001801170-25-000217 |
| 2025-08-0812:12 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001801170-25-000204 |
| 2025-08-0520:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001801170-25-000196 |
| 2025-06-1220:27 ET | 8-K | 5.07 Shareholder vote results | 0001801170-25-000154 |
| 2025-05-1412:59 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001801170-25-000141 |
| 2025-05-0912:05 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001801170-25-000132 |
| 2025-05-0620:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001801170-25-000127 |
| 2025-04-2820:05 ET | DEF 14A | Proxy statementPeriod 2025-04-28 | 0001801170-25-000104 |
| 2025-04-2221:24 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001801170-25-000088 |
| 2025-03-0313:03 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001801170-25-000052 |
| 2025-02-2721:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001801170-25-000049 |
| 2025-01-1314:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001801170-25-000029 |
| 2024-11-0813:08 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001801170-24-000234 |
| 2024-11-0621:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001801170-24-000231 |
| 2024-10-2520:05 ET | 8-K | 8.01 Other events | 0001801170-24-000220 |
| 2024-10-1021:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001801170-24-000204 |
| 2024-09-3020:05 ET | 8-K | 8.01 Other events | 0001801170-24-000195 |
| 2024-08-2213:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001801170-24-000182 |
| 2024-08-0812:06 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001801170-24-000165 |
| 2024-08-0520:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001801170-24-000158 |
| 2024-07-1920:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001801170-24-000152 |
| 2024-06-2620:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001801170-24-000137 |
| 2024-06-2520:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001801170-24-000135 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.